Skip to content
Review

Multifactorial Regulation of Inflammatory Bone Loss in Chronic Inflammatory and Immune-Associated Disorders: Osteoimmune Mechanisms and Translational Prospects of Natural Small Molecules

Jul 2026 · Calcified Tissue International · Vol 117 · 0 citations · 94 references
Medicine

TL;DR

The osteoimmune mechanisms through which persistent inflammation disrupts coupled bone remodeling are synthesized, with emphasis on RANKL-dependent osteoclastogenesis, suppressed osteoblast-supportive signaling, cytokine networks, immune-cell plasticity, and lesion microenvironment.

View source

Similar papers

Review Open access Aug 2026

Senescent immune cells, inflammaging, and bone loss: therapeutic potential and translational challenges of senolytics in osteoporosis

A structured research roadmap is proposed—centered on fate-mapping, lineage-specific depletion, and single-cell multi-omics—to convert the prevailing hypothesis into experimentally testable and clinically actionable evidence, while delineating the translational challenges that must be overcome to achieve precision seno...

Min-Shun Zhu, Jie Zhang, Hou-Shan Fang et al. · 0 citations
Review Open access Aug 2026

Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review

Background Osteoporosis is a systemic skeletal disorder characterized by reduced bone mass, impaired microarchitecture, and increased fracture risk. Patients with immune-mediated inflammatory diseases (IMIDs) have a higher prevalence of osteoporosis owing to chronic inflammation, glucocorticoid use, and disease-specifi...

Isabel de la Cámara-Fernández, T. Cobo-Ibáñez, Olga María Reillo-Sánchez et al. · 0 citations
Review Open access Aug 2026

Rewiring osteoimmune homeostasis in osteoporosis: T-cell subsets as key regulators and emerging therapeutic targets

A narrative synthesis of current evidence about the molecular mechanisms by which T-cell subsets regulate osteoporosis-related bone remodeling, the features of immune imbalance in different types of osteoporosis, T-cell-targeted intervention strategies, and translational challenges is provided to provide a theoretical...

Yuan Gong, Wen-Xing Zeng, Yi-Tao Liao et al. · 0 citations
Review Open access Sep 2026

Bone Marrow Immunometabolic Remodeling in Osteoporosis: From Systemic Risk Factors to Precision Intervention

Abstract Osteoporosis has traditionally been viewed as a bone remodeling disorder characterized by excessive bone resorption and inadequate bone formation. However, this paradigm does not fully explain its systemic heterogeneity, persistent progression, or variable therapeutic responses. This review reconceptualizes os...

Yu-Chang Ma, Shi-Yu Tian, Yao-Wen Zhang et al. · 0 citations
Review Open access Sep 2026

Gut microbiota-mediated Th17/Treg regulation in osteoporotic fracture: from postmenopausal dysbiosis to callus repair

Osteoporotic fractures are traditionally regarded as severe clinical consequences of low bone mass and impaired bone strength, but fracture risk and repair outcomes are also shaped by systemic inflammation, intestinal barrier integrity, microbial metabolism, and osteoimmune regulation. Increasing evidence indicates tha...

Zi-Xin Xu, Shu-Tao Jin, Yi-Ze Liu et al. · 0 citations
Review Open access Aug 2026

Sympathetic regulation of bone homeostasis and remodeling: molecular mechanisms, pathophysiological roles, and therapeutic implications

Bone metabolic disorders, such as osteoporosis, osteoarthritis, and rheumatoid arthritis, are characterized by disrupted skeletal homeostasis and represent major challenges in musculoskeletal health. Bone remodeling has long been interpreted as a coordinated process between osteoblast-mediated bone formation and osteoc...

Chang-Shun Huang, Shou-Xiang Kuang, Xi Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.